From genomic to epigenetic: the future of medicine
Life sciences not only contribute substantially to the health of populations around the world through the development of innovative diagnostic techniques, medical devices and new therapies, they also provide valuable input to fields including the nutritional sciences to enhance wellbeing and performance in all walks of life from sport and endurance to cognitive abilities and beauty.
For this reason, life sciences continue to be one of the fastest growing and most important industrial sectors in the global economy with Italian researchers and industrialists playing a key role, often in partnership with international research organisations and global companies.
With ever more attention dedicated to the predictive power of next generation genetic sequencing, particularly with reference to personalised medicine, fields like genomics and epigenomics are gaining in recognition and importance for the contribution they can make.
This year’s international conference will examine some of the key areas for future research and industrial development in the biotech field – genomics, epigenomics, biopharmaceutics and nutraceutics – and in the Medtech and E-Health sectors with insights into services and related activities. Key experts from both Italy and the international community will gather to share their experiences and visions and to address the burning question facing the future of life sciences in Italy and globally.